Génome
Jean-Marc Aury et al.
Long-read and chromosome-scale assembly of the hexaploid wheat genome achieves high resolution for research and breeding
GigaScience 2022, vol. 11
doi: 10.1093/gigascience/giac034
Victor S. Koko et al.
Artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers
Malaria Journal 2022, vol. 21, issue 1
doi: 10.1186/s12936-022-04140-7
Aurélie Canaguier et al.
Oxford Nanopore and Bionano Genomics technologies evaluation for plant structural variation detection
BMC Genomics 2022, vol. 23, issue 1
doi: 10.1186/s12864-022-08499-4
S. Cohen et al.
A POLD3/BLM dependent pathway handles DSBs in transcribed chromatin upon excessive RNA:DNA hybrid accumulation
Nature Communications 2022, vol. 13, issue 1
doi: 10.1038/s41467-022-29629-2
Ming Wen et al.
An ancient truncated duplication of the anti‐Müllerian hormone receptor type 2 gene is a potential conserved master sex determinant in the Pangasiidae catfish family
Molecular Ecology Resources 2022
doi: 10.1111/1755-0998.13620
Ming Wen et al.
An ancient truncated duplication of the anti‐Müllerian hormone receptor type 2 gene is a potential conserved master sex determinant in the Pangasiidae catfish family
Molecular Ecology Resources 2022, vol. 22, issue 6
doi: 10.1111/1755-0998.13620
Romain Laurent et al.
A genetic and linguistic analysis of the admixture histories of the islands of Cabo Verde
2022
doi: 10.1101/2022.04.11.487833
Elise Parey et al.
Genome structures resolve the early diversification of teleost fishes
2022
doi: 10.1101/2022.04.07.487469
Juliette Mainguené et al.
Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma
Molecular Oncology 2022, vol. 16, issue 16
doi: 10.1002/1878-0261.13219
Yann-Alexandre Vano et al.
Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial
The Lancet Oncology 2022, vol. 23, issue 5
doi: 10.1016/s1470-2045(22)00128-0